References
- Wassen L, Jertborn M. (2005). Kinetics of local and systemic immune responses after vaginal immunization with recombinant cholera toxin B subunit in humans. Clin Diagn Lab Immunol, 12:447–452.
- Fraillery D, Zosso N, Nardelli-Haefliger D. (2009). Rectal and vaginal immunization of mice with human papillomavirus L1 virus-like particles. Vaccine, 27:2326–2334.
- Zetola NM, Pilcher CD. (2007). Diagnosis and management of acute HIV infection. Infect Dis Clin North Am, 21:19–48, vii.
- Weber J, Desai K, Darbyshire J; Microbicides Development Programme. (2005). The development of vaginal microbicides for the prevention of HIV transmission. PLoS Med, 2:e142.
- Veazey RS, Klasse PJ, Ketas TJ, Reeves JD, Piatak M Jr, Kunstman K et al. (2003). Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection. J Exp Med, 198:1551–1562.
- Perioli L, Ambrogi V, Venezia L, Giovagnoli S, Pagano C, Rossi C. (2009). Formulation studies of benzydamine mucoadhesive formulations for vaginal administration. Drug Dev Ind Pharm, 35:769–779.
- D’Cruz OJ, Erbeck D, Uckun FM. (2005). A study of the potential of the pig as a model for the vaginal irritancy of benzalkonium chloride in comparison to the nonirritant microbicide PHI-443 and the spermicide vanadocene dithiocarbamate. Toxicol Pathol, 33:465–476.
- Garg S, Anderson RA, Chany CJ 2nd, Waller DP, Diao XH, Vermani K et al. (2001). Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM). Contraception, 64:67–75.
- Haineault C, Gourde P, Perron S, Désormeaux A, Piret J, Omar RF et al. (2003). Thermoreversible gel formulation containing sodium lauryl sulfate as a potential contraceptive device. Biol Reprod, 69:687–694.
- Mahaguna V, McDermott JM, Zhang F, Ochoa F. (2004). Investigation of product quality between extemporaneously compounded progesterone vaginal suppositories and an approved progesterone vaginal gel. Drug Dev Ind Pharm, 30:1069–1078.
- Taylor SJ, Peat JK, Armour CL. (1999). An evaluation of prostaglandin E2 vaginal gel use in practice. J Clin Pharm Ther, 24:303–310.
- Garg S, Jambu L, Vermani K. (2007). Development of novel sustained release bioadhesive vaginal tablets of povidone iodine. Drug Dev Ind Pharm, 33:1340–1349.
- Milani M, Molteni B, Silvani I. (2000). Effect on vaginal pH of a polycarbophil vaginal gel compared with an acidic douche in women with suspected bacterial vaginosis: a randomised, controlled study. Curr Therap Res, 61:781–788.
- das Neves J, Bahia MF. (2006). Gels as vaginal drug delivery systems. Int J Pharm, 318:1–14.
- Pavelic Z, Skalko-Basnet N, Jalsenjak I. (1999). Liposomes containing drugs for treatment of vaginal infections. Eur J Pharm Sci, 8:345–351.
- Pavelic Z, Skalko-Basnet N, Schubert R. (2001). Liposomal gels for vaginal drug delivery. Int J Pharm, 219:139–149.
- Pavelic Z, Skalko-Basnet N, Jalsenjak I. (2004). Liposomal gel with chloramphenicol: characterisation and in vitro release. Acta Pharm, 54:319–330.
- Pavelic Z, Skalko-Basnet N, Filipovic-Grcic J, Martinac A, Jalsenjak I. (2005). Development and in vitro evaluation of a liposomal vaginal delivery system for acyclovir. J Control Release, 106:34–43.
- Mashburn J. (2006). Etiology, diagnosis, and management of vaginitis. J Midwifery Womens Health, 51:423–430.
- Denning DW, Hope WW. (2010). Therapy for fungal diseases: opportunities and priorities. Trends Microbiol, 18:195–204.
- Albertinia B, Passerinia N, Sabatinoa M, Vitali B, Brigidi P, Rodrigueza L. (2009). Polymer–lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate. Eur J Pharm Sci, 6:591–601.
- Carrillo-Muñoz AJ, Brió S, Alonso R, del Valle O, Santos P, Quindós G. (2002). Ciclopiroxolamine: in vitro antifungal activity against clinical yeast isolates. Int J Antimicrob Agents, 20:375–379.
- Available at: www.profarma.az/en/preparat/5.html
- Available at: www.cipladoc.com/therapeutic/admin.php?mode=prod&action=disp&id=635
- Shaikh KS, Pawar AP. (2010). Liposomal delivery enhances cutaneous availability of ciclopirox olamine. Lat Am J Pharm, 29:763–770.
- Walash MI, Rizk MS, Eid MI, Fathy Mel S. (2006). Spectrofluorimetric determination of ciclopirox olamine via ternary complex with Tb(III) and EDTA. Acta Pharm, 56:431–440.
- Shaikh KS, Chellampillai B, Pawar AP. (2010). Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine. Drug Dev Ind Pharm, 36:946–953.
- Skalko N, Ajkovac M, Jalsˇenjak I. (1998). Liposomes with metronidazole for topical use: the choice of preparation method and vehicle. J Liposome Res, 8:283–293.
- Valenta C. (2005). The use of mucoadhesive polymers in vaginal delivery. Adv Drug Deliv Rev, 57:1692–1712.
- Owen DH, Katz DF. (1999). A vaginal fluid simulant. Contraception, 59:91–95.
- Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13:123–133.
- Neves J, Silva MV, Gonçalves MP, Amaral MH, Bahia MF. (2009). Rheological properties of vaginal hydrophilic polymer gels. Curr Drug Delivery, 6:83–92.
- Tavares GM, Galdorfini CB, Ribeiro HM, Lucia IV. (2010). Rheological characterization of hydrophilic gels. J Disper Sci Technol, 31:820–825.
- Chang JY, Oh YK, Choi HG, Kim YB, Kim CK. (2002). Rheological evaluation of thermosensitive and mucoadhesive vaginal gels in physiological conditions. Int J Pharm, 241:155–163.
- Rudraraju VS, Wyandt CM. (2005). Rheology of Microcrystalline Cellulose and Sodiumcarboxymethyl Cellulose hydrogels using a controlled stress rheometer: part II. Int J Pharm, 292:63–73.
- Owen DH, Peters JJ, Lavine ML, Katz DF. (2003). Effect of temperature and pH on contraceptive gel viscosity. Contraception, 67:57–64.
- Owen DH, Peters JJ, Katz DF. (2000). Rheological properties of contraceptive gels. Contraception, 62:321–326.
- Lai BE, Xie YQ, Lavine ML, Szeri AJ, Owen DH, Katz DF. (2008). Dilution of microbicide gels with vaginal fluid and semen simulants: effect on rheological properties and coating flow. J Pharm Sci, 97:1030–1038.
- Sassi AB, McCullough KD, Cost MR, Hillier SL, Rohan LC. (2004). Permeability of tritiated water through human cervical and vaginal tissue. J Pharm Sci, 93:2009–2016.
- Dittgen M, Durrani M, Lehman K. (1997). Acrylic polymers: a review of pharmaceutical applications. S T P Pharm Sci, 7:403–437.
- Boulmedarat L, Grossiord JL, Fattal E, Bochot A. (2003). Influence of methyl-β-cyclodextrin and liposomes on rheological properties of Carbopol 974P NF gels. Int J Pharm, 254:59–64.
- Owen DH, Peters JJ, Katz DF. (2001). Comparison of the rheological properties of Advantage-S and Replens. Contraception, 64:393–396.
- Chopra S, Motwani SK, Iqbal Z, Talegaonkar S, Ahmad FJ, Khar RK. (2007). Optimisation of polyherbal gels for vaginal drug delivery by Box-Behnken statistical design. Eur J Pharm Biopharm, 67:120–131.
- das Neves J, Amaral MH, Bahia MF. (2008). Performance of an in vitro mucoadhesion testing method for vaginal semisolids: influence of different testing conditions and instrumental parameters. Eur J Pharm Biopharm, 69:622–632.